AIM ImmunoTech Inc Share Price Today: Live Updates & Key Insights
AIM ImmunoTech Inc share price today is $0.249, up -0.4%. The stock opened at $0.2397 against the previous close of $0.25, with an intraday high of $0.2499 and low of $0.2397.
AIM ImmunoTech Inc Share Price Chart
AIM ImmunoTech Inc
AIM ImmunoTech Inc Share Price Performance
AIM ImmunoTech Inc Institutional Holdings
AIM ImmunoTech Inc Market Status
AIM ImmunoTech Inc Fundamentals
Market Cap 6.93 M
PB Ratio 3.306
PE Ratio 0.0
Enterprise Value 5.72 M
Total Assets 5.78 M
Volume 270872
AIM ImmunoTech Inc Company Financials
About AIM ImmunoTech Inc & investment objective
Company Information AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. It is also developing Ampligen for potential treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was founded in 1966 and is headquartered in Ocala, Florida.
Organisation Biotechnology
Employees 19
Industry Biotechnology
CEO Mr. Thomas K. Equels Esq., J.D., M.S.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
AIM ImmunoTech Inc FAQs
What is the share price of AIM ImmunoTech Inc today?
The current share price of AIM ImmunoTech Inc is $0.249.
Can I buy AIM ImmunoTech Inc shares in India?
Yes, Indian investors can buy AIM ImmunoTech Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy AIM ImmunoTech Inc shares in India?
You can easily invest in AIM ImmunoTech Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy AIM ImmunoTech Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of AIM ImmunoTech Inc.
Can I buy fractional shares of AIM ImmunoTech Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of AIM ImmunoTech Inc?
AIM ImmunoTech Inc has a market cap of $6.93 M.
In which sector does AIM ImmunoTech Inc belong?
AIM ImmunoTech Inc operates in the Biotechnology sector.
What documents are required to invest in AIM ImmunoTech Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of AIM ImmunoTech Inc?
The PE ratio of AIM ImmunoTech Inc is N/A and the PB ratio is 3.31.